Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction
Background. Drug-eluting stents (DES) have proven clinical superiority to bare-metal stents (BMS) for the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Decision to implant BMS or DES is dependent on the patient’s ability to take dual antiplatelet therapy. This study...
Saved in:
| Main Authors: | Jose F. Chavez, Jacob A. Doll, Anuj Mediratta, Francesco Maffessanti, Janet Friant, Jonathan D. Paul, John E. A. Blair, Sandeep Nathan, Neeraj Jolly, Atman P. Shah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2015/528753 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is there enough evidence for routine use of drug-eluting stents in acute myocardial infarction with ST segment elevation?
by: Tešić Milorad, et al.
Published: (2014-01-01) -
Treatment of intraprocedural stent thrombosis with intracoronary argatroban injection in ST-segment elevation myocardial infarction
by: Hiroshi Abe, et al.
Published: (2025-06-01) -
Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
by: Ji Young Park, et al.
Published: (2021-01-01) -
Proximal Left Main Coronary Artery Aneurysm Presenting as ST-Elevation Myocardial Infarction Treated by Stenting
by: Vijay Chander Vinod, et al.
Published: (2020-01-01) -
Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)